Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rhythmia Medical Inc.

Division of Boston Scientific Corp.
www.rhythmia.com

Latest From Rhythmia Medical Inc.

New Approaches To AF Ablation And Mapping

The market for atrial fibrillation catheter ablation devices continues to grow even as the field wrestles with basic questions and as new study results may dampen enthusiasm for some technologies. Though strategics dominate this sector, innovators with new approaches to ablation and mapping hope to help resolve unknowns and take a piece of this vast and underpenetrated market.

Market Intelligence Cardiovascular

Abbott Enters Electrophysiology Fray With Topera, ACT Deals

The diversified company is entering the atrial fibrillation catheter ablation for the first time. It is acquiring Afib ablation mapping system maker Topera and has gained rights to buy catheter developer Advanced Cardiac Therapeutics.

Medical Device

Bard EP Deal Latest In Boston Scientific’s M&A Revival, Bolsters CRM Business

Boston Scientific’s recent acquisition of Bard Electrophysiology marks the tenth notable acquisition that it has made since 2010. Four of those deals come in cardiac rhythm management, including EP, which is among the fastest-growing device sectors and one that company executives see as a major contributor to future growth.

Medical Device Business Strategies

New Product Briefs: Abbott Glucose Monitor, Boston Sci EP Mapping System Gain 510(k)s

Abbott’s FreeStyle Precision Pro blood glucose and beta-ketone monitoring system and Boston Scientific’s Rhythmia EP-mapping system earned 510(k) clearances. Also, Boston Sci’s OptiCross imaging catheter gained regulatory clearance in three countries. More new product news.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Boston Scientific Corp.
  • Senior Management
  • Leon Amariglio, Co-CEO
  • Contact Info
  • Rhythmia Medical Inc.
    Phone: (617) 591-9191
    111 South Bedford St.
    Ste. 205
    Burlington, MA 01803
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register